相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990-2016: evidence from Global Burden of Disease Study 2016
Rajesh Sharma
BREAST CANCER (2019)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2018)
Preventive, predictive, and personalized medicine for effective and affordable cancer care
Jaak Ph. Janssens et al.
EPMA JOURNAL (2018)
The crucial role of multiomic approach in cancer research and clinically relevant outcomes
Miaolong Lu et al.
EPMA JOURNAL (2018)
Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?
Alexander Winter et al.
BJU INTERNATIONAL (2017)
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Theo Vos et al.
LANCET (2017)
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016
Mohsen Naghavi et al.
LANCET (2017)
Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice
J. J. Tosoian et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2017)
Prostate Cancer Mortality-To-Incidence Ratios Are Associated with Cancer Care Disparities in 35 Countries
Sung-Lang Chen et al.
SCIENTIFIC REPORTS (2017)
Pattern recognition for predictive, preventive, and personalized medicine in cancer
Tingting Cheng et al.
EPMA JOURNAL (2017)
Prostate cancer in men of African origin
Kathleen F. McGinley et al.
NATURE REVIEWS UROLOGY (2016)
Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment
Scott A. Tomlins et al.
EUROPEAN UROLOGY (2016)
Familial Risk and Heritability of Cancer Among Twins in Nordic Countries
Lorelei A. Mucci et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016
Olga Golubnitschaja et al.
EPMA JOURNAL (2016)
Opportunistic Testing Versus Organized Prostate-specific Antigen Screening: Outcome After 18 Years in the Goteborg Randomized Population-based Prostate Cancer Screening Trial
Rebecka Arnsrud Godtman et al.
EUROPEAN UROLOGY (2015)
The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer
Stacy Loeb et al.
JOURNAL OF UROLOGY (2015)
Changes in Prognostic and Therapeutic Parameters in Prostate Cancer from an Epidemiological View over 20 Years
Martin Doerr et al.
ONCOLOGY RESEARCH AND TREATMENT (2015)
EPMA position paper in cancer: current overview and future perspectives
Godfrey Grech et al.
EPMA JOURNAL (2015)
Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
Gisele H. J. M. Leyten et al.
EUROPEAN UROLOGY (2014)
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
Fritz H. Schroder et al.
LANCET (2014)
Screening for Prostate Cancer: Results of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer
Monique J. Roobol et al.
EUROPEAN UROLOGY (2013)
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement
Virginia A. Moyer
ANNALS OF INTERNAL MEDICINE (2012)
Molecular Diagnosis of Prostate Cancer: PCA3 and TMPRSS2:ERG Gene Fusion
Maciej Salagierski et al.
JOURNAL OF UROLOGY (2012)
Modeling causes of death: an integrated approach using CODEm
Kyle J. Foreman et al.
POPULATION HEALTH METRICS (2012)
The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival
Fatemeh Asadzadeh Vostakolaei et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2011)
Comorbidity and Mortality Results From a Randomized Prostate Cancer Screening Trial
E. David Crawford et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
William J. Catalona et al.
JOURNAL OF UROLOGY (2011)
Prostate Cancer
James Mohler et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2010)
Evaluation of data quality in the cancer registry: Principles and methods Part II. Completeness
D. Max Parkin et al.
EUROPEAN JOURNAL OF CANCER (2009)
Why Are a High Overdiagnosis Probability and a Long Lead Time for Prostate Cancer Screening So Important?
Michael J. Barry et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Cancer screening in the United States, 2008: A review of current American Cancer Society guidelines and cancer screening issues
RobertA. Smith et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries
M Quinn et al.
BJU INTERNATIONAL (2002)
Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland.
P Lichtenstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
